Hanmi Pharm plans to release its new antihypertensive medicine Amorzaltan (amlodipine + losartan potassium) from next month, pinning a high hope on the new drug.
The safety and efficacy of Amorzaltan was already demonstrated in a variety of local clinical studies, said a spokesman of Hanmi Pharm.
The market for such drug is expected to hit by year end.
The Korean antihypertensive drug...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.